| Year |
Citation |
Score |
| 2020 |
Imamura T, Yanagihara YT, Ohyagi Y, Nakamura N, Iinuma KM, Yamasaki R, Asai H, Maeda M, Murakami K, Irie K, Kira JI. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model. Neurobiology of Disease. 137: 104739. PMID 31927145 DOI: 10.1016/j.nbd.2020.104739 |
0.344 |
|
| 2016 |
Zhou Q, Yen A, Rymarczyk G, Asai H, Trengrove C, Aziz N, Kirber MT, Mostoslavsky G, Ikezu T, Wolozin B, Bolotina VM. Impairment of PARK14-dependent Ca(2+) signalling is a novel determinant of Parkinson's disease. Nature Communications. 7: 10332. PMID 26755131 DOI: 10.1038/Ncomms10332 |
0.549 |
|
| 2015 |
Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T, Wolozin B, Butovsky O, Kügler S, Ikezu T. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nature Neuroscience. 18: 1584-93. PMID 26436904 DOI: 10.1038/Nn.4132 |
0.715 |
|
| 2015 |
Woodbury ME, Freilich RW, Cheng CJ, Asai H, Ikezu S, Boucher JD, Slack F, Ikezu T. miR-155 Is Essential for Inflammation-Induced Hippocampal Neurogenic Dysfunction. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 9764-81. PMID 26134658 DOI: 10.1523/Jneurosci.4790-14.2015 |
0.564 |
|
| 2014 |
Jun G, Asai H, Zeldich E, Drapeau E, Chen C, Chung J, Park JH, Kim S, Haroutunian V, Foroud T, Kuwano R, Haines JL, Pericak-Vance MA, Schellenberg GD, Lunetta KL, et al. PLXNA4 is associated with Alzheimer disease and modulates tau phosphorylation. Annals of Neurology. 76: 379-92. PMID 25043464 DOI: 10.1002/Ana.24219 |
0.595 |
|
| 2014 |
Asai H, Ikezu S, Woodbury ME, Yonemoto GM, Cui L, Ikezu T. Accelerated neurodegeneration and neuroinflammation in transgenic mice expressing P301L tau mutant and tau-tubulin kinase 1. The American Journal of Pathology. 184: 808-18. PMID 24418258 DOI: 10.1016/J.Ajpath.2013.11.026 |
0.717 |
|
| 2013 |
Asai H, Ikezu S, Sebastian K, Ikezu T. P4-026: The exosomal transcytosis mechanism of tau dissemination through neuron-microglia interaction Alzheimer's & Dementia. 9: P713-P713. DOI: 10.1016/J.Jalz.2013.05.1414 |
0.581 |
|
| 2013 |
Jun G, Asai H, Drapeau E, Park J, Zeldich E, Chen C, Kim S, Foroud T, Lunetta K, Kim J, Buxbaum J, Abraham C, Ikezu T, Mayeux R, Farrer L. O4-06-02: Genetic variation in PLXNA4 associated with susceptibility of Alzheimer's disease through tau phosphorylation Alzheimer's & Dementia. 9: P692-P692. DOI: 10.1016/J.Jalz.2013.04.366 |
0.613 |
|
| 2012 |
Asai H, Woodbury M, Ikezu S, Varnum M, Ikezu T. P2-144: Accelerated neurodegeneration and phenotypic switch of neuroinflammation in transgenic mice expressing P301L tau-mutant and tau-tubulin kinase 1 Alzheimer's & Dementia. 8: P309-P309. DOI: 10.1016/J.Jalz.2012.05.849 |
0.669 |
|
| 2012 |
Asai H, Ikezu S, Varnum M, Ikezu T. P4-040: Phosphorylation of collapsin response mediator protein-2 and axonal degeneration in transgenic mice expressing a familial Alzheimer's disease mutant of APP and tau-tubulin kinase 1 Alzheimer's & Dementia. 8: P649-P650. DOI: 10.1016/J.Jalz.2012.05.1741 |
0.696 |
|
| Show low-probability matches. |